Plain-English translation of NCT03413982 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This is a research registry—essentially a database—that collects medical information and biological samples from people with bladder cancer. Researchers will use this information to learn more about how bladder cancer develops, why it comes back in some patients, and what affects survival. Over time, this database will help scientists discover new ways to treat and prevent bladder cancer.
Bladder cancer can behave very differently from person to person, and doctors don't yet fully understand why some patients do well while others face recurrence or worse outcomes. By collecting samples and long-term follow-up information from many patients, researchers hope to identify patterns and develop better, more personalized treatments.
You likely qualify if…
You likely don't qualify if…
If you join, you will donate blood, urine, and tissue samples that researchers will store and study over time. There is no medication to take or special procedures beyond the sample collection. You can also participate in other research studies at the same time if you choose. The researchers will follow your medical records over the long term to track your health outcomes and learn how your cancer progresses.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States
Enrollment target
~1,000 participants
Started
November 2017
Primary completion
January 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jane Ladesma
University of Kansas Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.